![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Bharat Biotech Gets Indian Approval for COVID-19 Vaccine Trials
Bharat Biotech Gets Indian Approval for COVID-19 Vaccine Trials
Indian drugmaker Bharat Biotech has received approval to begin clinical trials of its COVID-19 vaccine candidate. It is the first trial approval for a domestic vaccine candidate.
The Hyderabad-based company is developing Covaxin, an inactivated vaccine derived from a strain of the SARS-CoV-2 virus isolated at India’s National Institute of Virology.
The phase 1/2 trials are scheduled to get underway across India in July.
Upcoming Events
-
21Oct